Literature DB >> 8806962

Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases.

C D Cascajo1, M Reichel, J L Sánchez.   

Abstract

The association of malignant neoplasms arising contiguous with or adjacent to seborrheic keratoses has been previously documented. In this study a retrospective analysis was performed to further characterize these combined neoplasms. A total of 54 examples of malignant neoplasms in conjunction with seborrheic keratoses were found, of which 43 were basal cell carcinomas, six were Bowen's disease, three were keratoacanthomas, and two were malignant melanomas. The average age of the patients was over 65 years. Men were affected more frequently then women. The posterior thorax was the most common site for malignant neoplasms associated with seborrheic keratoses. The superficial type of basal cell carcinoma was the most common type of basal cell carcinoma found in this association. All subtypes of seborrheic keratosis may be found together with malignant neoplasms. We believe the appellation collision tumor is not valid because it is unknown whether the association of seborrheic keratoses with malignant neoplasms is a random event or whether there is, in fact, a pathogenic relationship in the development of two distinctive neoplasms together. Therefore, the term compound tumor is proposed to designate the finding of two distinctive neoplasms either directly contiguous with each other or immediately adjacent to each other.

Entities:  

Mesh:

Year:  1996        PMID: 8806962     DOI: 10.1097/00000372-199606000-00007

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  14 in total

1.  Basal Cell Carcinoma Arising within Seborrheic Keratosis.

Authors:  Chan-Yang Lee; Ji-Youn Sung; Ki-Heon Jeong; Mu-Hyoung Lee
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

2.  Basal cell carcinoma arising within a seborrheic keratosis with respect to immunohistochemical characteristics.

Authors:  Mitsuaki Ishida; Noriko Ohsato; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2011-05-11       Impact factor: 2.967

3.  Basal Cell Carcinoma Arising within Seborrheic Keratosis.

Authors:  Recep Bedir; Cüneyt Yurdakul; Hasan Güçer; Ibrahim Sehitoglu
Journal:  J Clin Diagn Res       Date:  2014-07-20

4.  Seborrheic keratosis of the conjunctiva: a case report.

Authors:  Ji Hyun Kim; Hyoung Won Bae; Kwang Kil Lee; Tae Im Kim; Eung Kweon Kim
Journal:  Korean J Ophthalmol       Date:  2009-12-04

5.  Nodulocystic Basal Cell Carcinoma Arising Directly from a Seborrheic Keratosis: A Rare Case Report.

Authors:  Kana Shibao; Naoko Okiyama; Ryota Tanaka; Hitoshi Maruyama; Yasuhiro Fujisawa; Manabu Fujimoto
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

6.  Association between melanocytic neoplasms and seborrheic keratosis: more than a coincidental collision?

Authors:  Jennifer Defazio; Iris Zalaudek; Klaus J Busam; Carlo Cota; Ashfaq Marghoob
Journal:  Dermatol Pract Concept       Date:  2012-04-30

7.  Bowenoid transformation in seborrheic keratosis: A retrospective analysis of 429 patients.

Authors:  Parvin Rajabi; Neda Adibi; Pardis Nematollahi; Mitra Heidarpour; Mehdi Eftekhari; Amir Hossein Siadat
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

8.  Melanoma in-situ arising in seborrheic keratosis: a case report.

Authors:  Susan Repertinger; Jeff Wang; Edward Adickes; Deba P Sarma
Journal:  Cases J       Date:  2008-10-23

9.  Dysplastic nevus associated with seborrheic keratosis.

Authors:  Luciane Francisca Fernandes Botelho; Nilceo Schwery Michalany; Milvia Maria Simões e Silva Enokihara; Sergio Henrique Hirata
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

10.  Squamous Cell Carcinoma in-situ and Basal Cell Carcinoma Arising From Seborrheic Keratosis in the Same Patient.

Authors:  Divya Gupta; Nidhi Singh; Ajay Goyal; Pampa Ch Toi; Devinder Mohan Thappa
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.